Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shuxiu Xiao
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Zhongshan Hospital
Observed institutions:
Shanghai Medical College of Fudan University,
Shanghai Jiao Tong University,
Fudan University,
Tongren Hospital,
Zhongshan Hospital,
Shanghai Institute of Immunology
show all 6
ORCID:
0000-0003-3210-486X
Observed ORCID:
0000-0003-3210-486X
OpenAlex ID:
A5078045835
p38α signaling in Langerhans cells promotes the development of IL-17–producing T cells and psoriasiform skin inflammation
2018
·
Tingting Zheng
, Weiheng Zhao
, et al.
·
Science Signaling
·
37
miR-612 Enhances RSL3-Induced Ferroptosis of Hepatocellular Carcinoma Cells via Mevalonate Pathway
2023
·
Kailin Xing
, Xinyu Bian
, et al.
·
Journal of Hepatocellular Carcinoma
·
25
PDF
MAPK Phosphatase-1 Deficiency Exacerbates the Severity of Imiquimod-Induced Psoriasiform Skin Disease
2018
·
Weiheng Zhao
, Shuxiu Xiao
, et al.
·
Frontiers in Immunology
·
24
PDF
p38α deficiency ameliorates psoriasis development by downregulating STAT3-mediated keratinocyte proliferation and cytokine production
2024
·
Tingting Zheng
, Jiaqi Deng
, et al.
·
Communications Biology
·
23
PDF
LAYN Serves as a Prognostic Biomarker and Downregulates Tumor-Infiltrating CD8+ T Cell Function in Hepatocellular Carcinoma
2024
·
Shuxiu Xiao
, Lili Lu
, et al.
·
Journal of Hepatocellular Carcinoma
·
14
PDF
Clinical results of a phase 1 trial evaluating a HER2 directed CAR-T product selective for the tumor microenvironment (TME) in patients with GI and other solid tumor malignancies.
2025
·
Yuhong Zhou
, Qian Li
, et al.
·
Journal of Clinical Oncology
·
7
TRPV4 drives the progression of leiomyosarcoma by promoting ECM1 generation and co-activating the FAK/PI3K/AKT/GSK3β pathway
2024
·
Qiwen Zhou
, Yang You
, et al.
·
Cellular Oncology
·
7
PDF
Tumor infiltrating B lymphocytes (TIBs) associate with poor clinical outcomes, unfavorable therapeutic benefit and immunosuppressive context in metastatic clear cell renal cell carcinoma (mccRCC) patients treated with anti-PD-1 antibody plus Axitinib
2024
·
Zhiyuan Lin
, Shuxiu Xiao
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
6
Dual role of interleukin-2 in tumor-infiltrating lymphocyte therapy
2026
·
Lili Lu
, Wenjia Zhuang
, et al.
·
Clinical Cancer Bulletin
PDF
Show more works
View as search
Works count:
9
Citation count:
142
H-index:
7
I10-index:
5
Year
Topic
Type